Jean-Pierre Bronowicki, MD, Ph.D., Department of Hépato-Gastroenterologie, Centre Hospitalier Universitaire de Nancy-Brabois, Vandoeuvre-lès-Nancy, France
Dr. Bronowicki is a hepatologist and gastroenterologist and is recognized as an expert in HCV infection, frequently serving as a consultant to the EMEA and other European regulatory agencies. He has published more than 60 papers in the field.
Selected & Recent publications:
Zarski JP, Bedossa P, Bronowicki JP, Doffoel M, Poynard T. 2007. Non invasive markers using for the assessment of fibrosis in hepatitis C. Gastroenterol Clin Biol. Aug-Sep;31(8-9 Pt 3):4S34-9.
Abergel A, Hezode C, Leroy V, Barange K, Bronowicki JP, Tran A, Alric L, Castera L, Bernard PH, Henquell C, Lafeuille H, Ughetto S, Darcha C, Chevallier M, Martineau N, Dubost S, Randl K, Dhumeaux D, Bommelaer G, Bonny C; French multicenter study group. 2006. Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b. J Viral Hepat. Dec;13(12):811-20.
Bronowicki JP, Ouzan D, Asselah T, Desmorat H, Zarski JP, Foucher J, Bourlière M, Renou C, Tran A, Melin P, Hézode C, Chevalier M, Bouvier-Alias M, Chevaliez S, Montestruc F, Lonjon-Domanec I, Pawlotsky JM. 2006. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. Gastroenterology. Oct;131(4):1040-8.